NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 294 filers reported holding NEKTAR THERAPEUTICS in Q3 2019. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $0 | -100.0% | 34 | -99.3% | 0.00% | -100.0% |
| Q2 2022 | $19,000 | – | 4,946 | +10891.1% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 45 | -40.0% | 0.00% | – |
| Q4 2021 | $1,000 | -94.1% | 75 | -91.9% | 0.00% | -100.0% |
| Q3 2021 | $17,000 | -19.0% | 926 | -25.7% | 0.00% | 0.0% |
| Q2 2021 | $21,000 | +16.7% | 1,247 | +34.8% | 0.00% | 0.0% |
| Q1 2021 | $18,000 | -50.0% | 925 | -55.5% | 0.00% | 0.0% |
| Q4 2020 | $36,000 | +200.0% | 2,080 | +186.5% | 0.00% | +33.3% |
| Q3 2020 | $12,000 | +71.4% | 726 | +132.7% | 0.00% | +50.0% |
| Q2 2020 | $7,000 | – | 312 | +1460.0% | 0.00% | – |
| Q1 2020 | $0 | – | 20 | +150.0% | 0.00% | – |
| Q2 2019 | $0 | – | 8 | +14.3% | 0.00% | – |
| Q4 2018 | $0 | – | 7 | +40.0% | 0.00% | – |
| Q2 2018 | $0 | -100.0% | 5 | 0.0% | 0.00% | -100.0% |
| Q1 2018 | $1,000 | – | 5 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | – | 5 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 1,828,400 | $89,281,000 | 6.61% |
| Cormorant Asset Management, LP | 1,500,000 | $73,245,000 | 5.42% |
| Camber Capital Management LP | 2,000,000 | $97,660,000 | 3.76% |
| Rhenman & Partners Asset Management AB | 617,652 | $30,160,000 | 3.09% |
| BRIDGER MANAGEMENT, LLC | 1,134,414 | $55,393,000 | 3.00% |
| First Light Asset Management, LLC | 374,251 | $18,275,000 | 2.84% |
| Gs Investments, Inc. | 54,000 | $2,636,820,000 | 1.97% |
| SABBY MANAGEMENT, LLC | 241,922 | $11,813,000 | 1.82% |
| QUANTRES ASSET MANAGEMENT Ltd | 50,000 | $2,441,000 | 1.41% |
| Tibra Equities Europe Ltd | 173,183 | $8,457,000 | 1.27% |